Therefore, SLC48A1 may act as a critical molecular link connecting lesion hemorrhage to disease progression via the heme iron recycling–iron overload–oxidative stress axis, representing a potential therapeutic target in endometriosis. This evidence concerns the gene SLC48A1 and endometriosis.